ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1599

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making

Courtney Wells1, Guadalupe Torres2, William Nowell3, Shilpa Venkatachalam3, Laura Stradford4, Kelly Gavigan3, Barbara Boyd-Floering5, Maria I. Danila6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Patient Partner, Brooklyn Center, MN, 3Global Healthy Living Foundation, Upper Nyack, NY, 4Global Healthy Living Foundation, Nyack, NY, 5Whelton Virshup CreakyJoints Arthritis Clinic/ Global Healthy Living Foundation, Lake Worth, FL, 6University of Alabama at Birmingham, Birmingham, AL, 7Independent, San Diego, CA

Meeting: ACR Convergence 2021

Keywords: COVID-19, health behaviors, mental health, Qualitative Research, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: The purpose of this qualitative study was to understand the concerns, behaviors, and experiences of adults with autoimmune rheumatic conditions, and to evaluate the impact of the COVID-19 pandemic on their quality of life. Intentional efforts were made to amplify a diverse range of patient voices. Recruitment methods purposefully targeted persons who identify as Black, Indigenous, and People of Color (BIPOC) and/or part of underrepresented and underserved communities.

Methods: Between December 2020 – May 2021, 60-minute interviews were conducted with English- and Spanish-speaking adults, aged ≥ 18 years with self-reported diagnosis of autoimmune rheumatic condition, via phone or videoconference using a semi-structured interview guide. Participants were recruited through social media posts, word-of-mouth, or clinical referral. To ensure rigor while maintaining relevance in response to the changing nature of the COVID-19 pandemic, the research team met regularly to perform preliminary analysis and reflexivity (e.g., acknowledging researchers’ pre-conceptions). Ongoing analysis combined methods of phenomenology and content analysis through three steps: 1. Summarizing interviews, 2. Discussing potential units of meaning based on iterative review of transcripts and literature, 3. Axial and selective coding to determine cross-cutting themes.

Results: Participants included 19 adults (40.3 ± 15.1 years old), most reporting a diagnosis of rheumatoid arthritis (52.6%). Demographics included race (52.6% BIPOC), ethnicity (31.6% Hispanic/Latinx), insurance (21.1% Medicare/Medicaid; 15.8% uninsured), employment (26.3% identified as disabled), and representation across U.S. geographic locations. Ongoing analysis produced four preliminary themes (Table 1).

  • Theme 1: Based on their learned and experiential knowledge of rheumatic disease and its treatment, most participants perceived themselves to be at higher risk for COVID-19 than the general population.
  • Theme 2: Participants vigilantly worked to balance COVID-19 risk, disease management, and mental health. Participants’ decisions of whether, how, and when to engage in activities often centered around trust or distrust in their social circles, local geographic communities, and United States politics and public health response.
  • Theme 3: Participants felt unsupported by all levels of the healthcare system, from direct interaction with providers to messages received from public health authorities.
  • Theme 4: Combined, these factors led to a self-reported increase in autoimmune disease symptoms; relapse or exacerbation of established mental health conditions; and/or new symptoms of trauma, depression, and/or anxiety.

Conclusion: Participant interviews during the COVID-19 pandemic revealed critical patient needs for direct and timely communication as well as increased sensitivity to the psychosocial effects of the pandemic on disease symptoms. It is likely these needs will persist post-pandemic.

Table 1. Sample Quote(s) per Qualitative Theme


Disclosures: C. Wells, None; G. Torres, None; W. Nowell, Global Healthy Living Foundation, 3, AbbVie, 5, Amgen, 5, Eli Lilly, 5; S. Venkatachalam, None; L. Stradford, None; K. Gavigan, Global Healthy Living Foundation, 3; B. Boyd-Floering, None; M. Danila, Boehringer Ingelheim, 5, Amgen, 1, Amgen, 5, AbbVie, 1, Pfizer, 5, Pfizer, 11, Horizon, 5, Novartis, 1, WebMD, 12, writer; K. Carandang, None.

To cite this abstract in AMA style:

Wells C, Torres G, Nowell W, Venkatachalam S, Stradford L, Gavigan K, Boyd-Floering B, Danila M, Carandang K. Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/impact-of-the-covid-19-pandemic-on-the-quality-of-life-of-patients-with-rheumatic-conditions-a-qualitative-analysis-of-perceived-risk-and-decision-making/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-the-covid-19-pandemic-on-the-quality-of-life-of-patients-with-rheumatic-conditions-a-qualitative-analysis-of-perceived-risk-and-decision-making/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology